REPORT ID 20667

Global Non-Invasive Prenatal Testing (NIPT) Market -Analysis and Forecast2019-2023

Publish Date
2019
Pages
0
Format
Electronic (PDF)

Non-invasive prenatal testing (NIPT) is an innovative way of screening pregnancies for fetal chromosomal aneuploidies by analyzing fetal cell-free DNA circulating in maternal blood. Amniocentesis, chorionic villus sampling (CVS), maternal serum screening, and nuchal translucency (NT) scan have been the primary diagnostic and screening methods for chromosomal abnormalities. The growth of NIPT market is attributed primarily to a rapid increase in genetic disorders/abnormalities, increase in fetal mortality, adoption of NIPT test in developed countries, and advancement of healthcare technologies.

In spite of enormous competition levels that prevails in the industry, the market growth is expected to be propelled by multiple factors such as rising demand for prenatal testing, adoption toward IVF procedures, increasing awareness among parents, and upsurge in the government spending on healthcare. 

The research study has segmented the entire NIPT market into test value and volume, and geographical region including detail country analysis which enables the user gain a multi-dimensional view of the market. The research report employs an exhaustive and analytical approach to estimate and understand the market thus provides an all-inclusive insight into various forms of developments, market trends and strategies. While underlining the key driving and restraining factors for the NIPT market, the report also provides a comprehensive understanding in terms of competitive landscape, market share analysis, competitor benchmarking (matrices), and their positioning within the global NIPT market.

The following questions have been answered in this report:
•    What are the major market drivers, challenges and opportunities of the global NIPT market and their use cases?
•    What are the key technological developments taking place in the NIPT market?
•    What is the market share of the leading segments and sub-segments of the global NIPT market during the forecast period (2017-2023)?
•    How will each segment of the global NIPT market grow over the forecast period and the revenue share for each of them by the end of 2023?
•    Who are the leading players in the global NIPT market (2016)?
•    Which geographical region will have the highest growth rate (CAGR) during the forecast period?
•    What are the key development strategies employed by the key players across various geographies?
•    What are the market trends and key developments in different geographical regions?
•    What is the role of various regulatory and governmental agencies in global NIPT market across various geographical locations?
•    What are the major consumer preferences while purchasing or undergoing an NIPT test?

The report includes the company profiles for leading players in the NIPT market which enables the readers understand the current competitive scenario that prevails in this industry. Some of the key player include Roche, Natera, Illumina, LabCorp, LifeCodexx, BGI Diagnostics, Premaitha and Berry Genomics, among others. 
			   
Executive Summary
1	Report Scope & Methodology
1.1	Scope of the Report
1.2	Global NIPT Market Segmentation
1.3	Key Learnings
1.4	Research Methodology
1.4.1	Data Triangulation
1.4.2	Key Data Points from Secondary Sources
1.4.3	Key Data Points from Primary Sources
1.4.4	Top-Down Approach (Segment Analysis)
1.4.5	Bottom-Up-Approach (Segment Analysis)
1.4.6	Assumptions and Limitations
1.4.7	Data and Prediction Modelling
2	Market Overview
2.1	Introduction
2.2	Benefits and Risks of NIPT
2.3	Technological Approach for NIPT
2.4.1	Fetal Cell Maternal Blood (FCMB)
2.4.2	Cell-Free NIPT Test
2.5	Patent Landscape
2.6	World Economic Outlook of Prenatal Testing Market, 2016
3.	Market Dynamics
3.1	Market Drivers
3.2	Market Challenges
3.3	Market Opportunities
4	Major Chromosomal Aneuploidies
5	Competitive Landscape
5.1	Key Developments & Strategies
5.2	Market Attractiveness Analysis: Global Non-Invasive Prenatal Testing Market, by Geography
5.3	Growth Share Matrix
5.4	Porter’s Five Forces Analysis
5.5	Value Chain Analysis
6.	Global NIPT Market, By Test (Volume and Value)
6.1	Market Overview
6.2	Panorama Test
6.3	Sequenom Test 
6.4	Harmony Test
6.5	NIFTY Test
6.6	verifi Test
6.7	IONA Test
6.8	Prena Test
6.9	BambniTest
6.10	Other NIPT Tests
7	Global NIPT Market, By  Geography(Volume and Value)
7.1	Geographical Scenario
7.2	North America
7.3	Europe
7.4	Asia Pacific
7.5	Rest of the World (RoW)
8	End User Perception
9	Company Profiles
9.1	Laboratory Corporation of America
9.2	Roche AG
9.3	Premaitha Health Plc
9.4	Illumina Inc.
9.5	Natera Inc.
9.6	Quest Diagnostics
9.7	BGI Diagnostics
9.8	LifeCodexx AG
9.9	Berry Genomics
9.10	NIPD Genetics
List of Tables
Table: 1	Global Non-Invasive Prenatal Testing (NIPT) Market (2016 & 2023)
Table: 2	Technological Approach for NIPT
Table: 3	Patent Landscape
Table: 4	Types Of Genetic Diseases In Fetuses: An Overview
Table: 5	Major Chromosomal Aneuploidies and their Incidence Rate
Table: 6	Recent Partnerships & Collaborations
Table: 7	Recent Product Launch & Developments
Table: 8	Recent Merger & Acquisitions
Table: 9	Recent Patent , Certifications, Infringements & Approvals
Table: 10	Global NIPT Market Value by Test Type, 2016-2013 (In Units)
Table: 11	North America Market Scope Statistics
Table: 12	North America NIPT Market by Test Value, 2016-2023 ($Million)
Table: 13	Europe NIPT Market by Test Value, 2016-2023 ($Million)
Table: 14	Europe NIPT Market by Test Volume, 2016-2023 (in Units)
Table: 15	Europe NIPT Market by Country, 2016-2023 (in Units)
Table: 16	Europe: Recent Developments
Table: 17	APAC NIPT Market by Test Volume, 2016-2023 ($Million)
Table: 18	APAC NIPT Market by Test Value, 2016-2023 (in Units)
Table : 19	APAC NIPT Market by Country, 2016-2023 (in Units)
Table: 20	ROW NIPT Market by Test value, 2015-2023 (in Units)
Table: 21	ROW NIPT Market by Test Volume, 2015-2023 (in Units)
List of Figures
1	Global NIPT Market by Volume, 2016-2023 (in Units)
2	Global NIPT Market Value, 2016-2023 ($Million)
3	NIPT Market Value by Test Type, 2016
4	NIPT Market Value by Test Type, 2023
5	NIPT Market Volume by Test Type, 2016
6	NIPT Market Volume by Test Type, 2023
7	Global NIPT Market Value by Geography, 2016 & 2023 ($Million)
8	Global NIPT Market Volume by Geography, 2016 & 2023 (in Units)
9	Global NIPT Market Segmentation
10	Research Methodology
11	Data Triangulation
12	Top-Down Approach (Segmental Analysis)
13	Bottom-Up Approach (Segmental Analysis)
14	Assumptions and Limitations
15	NIPT: Overall Process
16	Global Prenatal Testing Market: Opportunity Matrix
17	Ecosystem Players Of Global Prenatal Testing Market
18	Prenatal Testing Timeline During Pregnancy
19	Market Dynamics
20	Market Share Analysis, 2016
21	Market Share Analysis, 2023
22	Growth Share Matrix, 2016
23	Porter’s Five Forces Analysis
24	Value Chain Analysis
25	Panorama Test  by Volume, 2016-2023 (in Units)
26	Panorama Test by Value, 2016-2023 ($Million)
27	Panorama Test Volume by Geography, 2016-2023 (in Units) 
28	Sequenom Test by Volume, 2016-2023 (in Units)
29	Sequenom Test by Value, 2016-2023 ($Million)
30	Sequenom Test Volume by Geography, 2016-2023 (in Units) 
31	Sequenom Test  Value by Geography, 2016-2023 ($Million) 
32	Harmony Test by Volume, 2016-2023 (in Units)
33	Harmony Test by Value, 2016-2023 ($Million)
34	Harmony Test Volume by Geography, 2016-2023 (in Units)
35	Harmony Test Value by Geography, 2016-2023 ($Million)
36	NIFTY Test by Volume, 2016-2023 (in Units)
37	NIFTY Test by Value, 2016-2023 ($Million)
38	NIFTY Test Volume by Geography, 2016-2023 (in Units) 
39	NIFTY Test Value by Geography, 2016-2023 ($Million) 
40	verifi Test by Volume, 2016-2023 (in Units)
41	verifi Test by Value, 2016-2023 ($Million)
42	verifi Test Volume by Geography, 2016-2023 (in Units) 
43	verifi Test Value by Geography, 2016-2023 ($Million) 
44	IONA Test by Volume, 2016-2023 (in Units)
45	IONA Test by Value, 2016-2023 ($Million)
46	IONA Test Volume by Geography, 2016-2023 (in Units) 
47	IONA Test Value by Geography, 2016-2023 ($Million) 
48	Prena Test by Volume, 2016-2023 (in Units)
49	Prena Test by Value, 2016-2023 ($Million)
50	Prena Test Volume by Geography, 2016-2023 (in Units) 
51	Prena Test Value by Geography, 2016-2023 ($Million) 
52	BambniTest by Volume, 2016-2023 (in Units)
53	BambniTest by Value, 2016-2023 ($Million)
54	BambniTest  Volume by Geography, 2016-2023 (in Units) 
55	BambniTest Value by Geography, 2016-2023 ($Million) 
56	Other NIPT Tests by Volume, 2016-2023 (in Units)
57	Other NIPT Tests by Value, 2016-2023 ($Million)
58	Other NIPT Tests Volume by Geography, 2016-2023 (in Units) 
59	Other NIPT Tests Value by Geography, 2016-2023 ($Million) 
60	NIPT Market Value by Geography, 2016-2023 ($Million)
61	NIPT Market Volume by Geography, 2016-2023 (in Units)
62	Key Factors Influencing Decision about NIPT Market
63	Influence of GPs, Labs, and KOLs on Decision Making
64	Willingness to Purchase NIPT Tests
65	Technology Preferences 
66	Perception about Pricing 
67	Perception about Brand 
68	Selection Criteria for NIPT Tests 
69	Sources of Information about NIPT
70	Information Required to Purchase a new Test 
71	Preferred Channel for Purchasing
72	Laboratory Corporation of America Financials
73	Roche AG Financials
74	Premaitha Health Plc Financials
75	Illumina Inc. Financials
76	Natera Inc. Financials
77	Quest Diagnostics Incorporated Financials